Quoin Pharmaceuticals
QNRX
7 hedge funds and large institutions have $82.2K invested in Quoin Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.04% less ownership
Funds ownership: 0.16% → 0.12% (-0.04%)
30% less funds holding
Funds holding: 10 → 7 (-3)
36% less capital invested
Capital invested by funds: $128K → $82.2K (-$45.4K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$15.1K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$15.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.05K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$3.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$59.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.97K |
| 3 |
Two Sigma Investments
New York
|
-$6.33K |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$6.03K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$580 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $19.1K | +$2.69K | +128 | +13% |
|
|
TSS
2
Two Sigma Securities
New York
| $15.7K | +$5.05K | +240 | +36% |
|
|
VF
3
Virtu Financial
New York
| $13K | +$15.1K | +719 | New |
|
|
RJFSA
4
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $12.4K | +$15.1K | +718 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $11.3K | +$10.1K | +478 | +275% |
|
|
6
RhumbLine Advisers
Boston,
Massachusetts
| $10.5K | +$3.6K | +171 | +40% |
|
7
JP Morgan Chase
New York
| $326 | – | – | – |
|
|
HNB
8
Huntington National Bank
Columbus,
Ohio
| $6 | – | – | – |
|
|
ACM
9
Altium Capital Management
New York
| – | -$59.8K | -2,946 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$8.97K | -441 | Closed |
|
|
11
Two Sigma Investments
New York
| – | -$6.33K | -312 | Closed |
|
|
OIA
12
OneDigital Investment Advisors
Overland Park,
Kansas
| – | -$6.03K | -297 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$580 | -29 | Closed |
|
QNRX Hedge Fund Activity: Q3 2024 in Review
7 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2024, worth a combined $82.2K — down 36% from $128K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of QNRX and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $15.1K. The largest seller was Altium Capital Management, exiting entirely with an estimated $59.8K sold.
- 7 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q3 2024, down from 10 in Q2 2024.
- Funds reported $82.2K of Quoin Pharmaceuticals stock for Q3 2024, down 36% quarter-over-quarter.
- 2 funds opened new Quoin Pharmaceuticals positions in Q3 2024 and 5 closed out, a net change of -3 holders.
- The largest Quoin Pharmaceuticals buyer in Q3 2024 was Virtu Financial, an estimated $15.1K added.
- The largest Quoin Pharmaceuticals seller in Q3 2024 was Altium Capital Management, an estimated $59.8K sold.
Based on aggregated 13F filings for Q3 2024.